Plegridy Market Report 2026

Plegridy Market Overview

• The Plegridy market growth in the historic period has been driven by increasing prevalence of multiple sclerosis diagnoses, availability of interferon-based therapies • Market expansion is supported by increasing demand for improved patient adherence solutions, rising investments in ms drug innovation • Growth Driver: Surge In Multiple Sclerosis Diagnoses Anticipated To Propel Plegridy Adoption • North America was the largest region in 2025.

What Is Covered Under Plegridy Market?

Plegridy (generic name: peginterferon beta-1a) is a prescription medication used to treat relapsing forms of multiple sclerosis (MS), a chronic disease that affects the central nervous system. It helps reduce the frequency of relapses and slows the progression of physical disability in people with MS. The main route of administration for plegridy is subcutaneous (SC) injection and intramuscular (IM) injection. A subcutaneous injection involves delivering medication into the layer of fatty tissue under the skin using a short needle. This method is commonly chosen for its convenience and slower release of medication into the bloodstream. It is administered through subcutaneous injection, allowing patients to self-manage their treatment. This method is particularly suitable for clinical indications such as relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS). Plegridy is distributed through various channels, including direct sales, online pharmacies, and wholesale distributors, and is utilized by hospitals and clinical research laboratories.

What Is The Plegridy Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for improved patient adherence solutions, rising investments in ms drug innovation, expansion of personalized neurology care, growing focus on long-term disease management, advancements in biologic drug delivery systems. Major trends in the forecast period include increasing adoption of long-acting ms therapies, rising demand for reduced injection frequency treatments, growing focus on disease-modifying therapies, expansion of patient-centric treatment models, enhanced monitoring of treatment outcomes.

Global Plegridy Market Segmentation

1) By Roue Of Administration: Subcutaneous (SC) Injection, Intramuscular (IM) Injection 2) By Clinical Indication: Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS) With Relapses 3) By Distribution Channel: Direct Sales, Online Pharmacies, Wholesale Distributors 4) By End User: Hospitals, Clinical Research Laboratories

What Are The Drivers Of The Plegridy Market?

The increasing prevalence of multiple sclerosis is expected to drive the growth of the plegridy market going forward. Multiple sclerosis is a chronic autoimmune disorder in which the immune system mistakenly attacks the myelin, the protective sheath surrounding nerve fibers in the central nervous system, leading to disrupted communication between the brain and the body and resulting in various neurological symptoms. The increasing prevalence of multiple sclerosis is attributed to a combination of environmental factors, improved diagnostic techniques, increased awareness and recognition of the disease, and lifestyle changes such as obesity and vitamin D deficiency, particularly among women. Plegridy is used in patients with multiple sclerosis to reduce relapse rates and slow disease progression by modulating the immune system. For instance, in May 2024, according to a report published by the Multiple Sclerosis Trust, a UK-based national charity, over 150,000 people in the UK live with multiple sclerosis, with new diagnoses rising by over 7,100 each year. Further, multiple sclerosis cases have increased by up to 15% across regions and are most often diagnosed in those in their 30s and 40s. Therefore, the rising prevalence of multiple sclerosis drives the growth of the plegridy industry. The increasing healthcare spending is expected to propel the growth of the plegridy market going forward. Healthcare spending refers to the total expenditures on healthcare goods and services, including personal health care, preventive services, public health initiatives, and health administration, to improve health outcomes. The increasing healthcare spending is driven by population growth, an aging population, a rise in chronic illnesses, and higher medical services and prescription drug costs. The increasing healthcare spending boosts pledgity by expanding access to treatment, improving patient awareness, and supporting healthcare infrastructure for multiple sclerosis care. For instance, in August 2023, according to a report published by the National Health Service Confederation, a UK-based membership organization, in the 2022-23 fiscal year, the National Health Service (NHS) England was allocated a total of $152.6 billion, of which $107.8 billion, more than 70% of the total budget, was assigned to integrated care boards. Therefore, the increasing healthcare spending is driving the growth of the plegridy industry. The growing adoption of biologics is expected to drive the expansion of the plegridy market in the future. Biologics are complex medications derived from living organisms, including proteins and antibodies, used to treat various diseases by explicitly targeting biological processes in the body. The increasing use of biologics is driven by their effectiveness in treating a wide range of diseases, advances in biotechnology, and a growing demand for targeted therapies that address complex medical conditions. The use of biologics in multiple sclerosis treatment has boosted plegridy's growth by offering a more targeted, effective, and convenient therapy option for patients. For instance, in August 2025, according to the National Institutes of Health (NIH), a US-based biomedical research agency, in 2024, the FDA authorized 50 new medicines, including 16 biologics, and notably, six of those biologic approvals occurred in the first half of the year. Thus, the increasing use of biologics is driving the growth of the plegridy industry.

Key Players In The Global Plegridy Market

Major companies operating in the plegridy market are Biogen Inc.

Regional Insights

North America was the largest region in the plegridy market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Plegridy Market?

The plegridy market consists of sales of plegridy (peginterferon beta-1a) injection and auto-injectors (plegridy pen). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Plegridy Market Report 2026?

The plegridy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the plegridy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.